Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.660
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
0.678
+0.018 (2.71%)
Pre-market: Apr 29, 2026, 6:09 AM EDT
Impact BioMedical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 71 | 53 | 17 | - | - | - | |
| Market Cap Growth | 1054.56% | 216.73% | - | - | - | - | |
| Enterprise Value | 71 | 79 | 25 | - | - | - | |
| Last Close Price | 0.66 | 0.51 | 1.45 | - | - | - | |
| PS Ratio | 2223.81 | 1651.05 | - | - | - | - | |
| PB Ratio | 5.48 | 3.40 | 2.31 | - | - | - | |
| EV/Sales Ratio | 2223.72 | 2459.96 | - | - | - | - | |
| Debt / Equity Ratio | - | - | 1.23 | 0.43 | 0.31 | 0.31 | |
| Net Debt / Equity Ratio | 0 | 0 | 0.95 | 0.43 | 0.31 | 0.31 | |
| Net Debt / EBITDA Ratio | 0.00 | 0.00 | -2.03 | -3.00 | -4.36 | -6.02 | |
| Net Debt / FCF Ratio | 0.00 | 0.00 | -2.41 | -4.21 | -3.97 | -6.16 | |
| Asset Turnover | 0.00 | 0.00 | - | - | 0.00 | - | |
| Quick Ratio | 0.01 | 0.01 | 0.20 | 0.01 | 0 | 0.00 | |
| Current Ratio | 0.35 | 0.35 | 0.25 | 0.03 | 0.01 | 0.02 | |
| Return on Equity (ROE) | -104.16% | -104.16% | -139.55% | -14.46% | -19.99% | -4.52% | |
| Return on Assets (ROA) | -14.16% | -14.16% | -6.54% | -5.53% | -4.13% | -3.81% | |
| Return on Capital Employed (ROCE) | -26.30% | -26.30% | -32.30% | -12.80% | -9.50% | -7.30% | |
| Earnings Yield | -16.64% | -22.41% | -148.12% | - | - | - | |
| FCF Yield | -2.66% | -3.58% | -17.11% | - | - | - | |
| Buyback Yield / Dilution | -193.30% | -193.30% | 82.14% | 14.54% | 0.00% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.